AWM Investment Company Inc. 13D/13G Filings for OncoCyte Corporation (OCX)

AWM Investment Company Inc. 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
3:47 pm
Purchase
2023-12-3113GOncoCyte Corporation
OCX
AWM Investment Company Inc.754,286
9.100%
391,575increase
(+107.96%)
Filing
2023-02-14
11:23 am
Purchase
2022-12-3113GOncoCyte Corporation
OCX
AWM Investment Company Inc.362,711
6.100%
362,711increase
(New Position)
Filing